In vivo three-dimensional imaging of neovascular age-related macular degeneration using optical frequency domain imaging at 1050 nm.

PURPOSE To assess the application of optical frequency domain imaging (OFDI) at 1050 nm for the detection of choroidal neovascularization (CNV) in age-related macular degeneration (AMD) and its response to treatment. Three patients presenting with blurred vision and exudative AMD were imaged before and after anti-VEGF treatment with ranibizumab. METHODS The patients were imaged with OFDI, a swept-source-based, high-speed optical coherence tomography (OCT) system developed at the Wellman Center for Photomedicine. A center wavelength of 1050 nm was used that has been demonstrated to provide better imaging of the deeper structures of the retina below the RPE, such as the choroidal vasculature. Three-dimensional data sets were acquired in 2 to 4 seconds. RESULTS En face images were compiled from cross-sectional OFDI data and correlated with color fundus photography (CF) and fluorescein angiograms (FAs). Cross-sectional images were coregistered with CF and FA to obtain depth-resolved information about CNV, CNV volume, retinal thickness, subretinal fluid volume and height of neurosensory detachment before and after treatment with ranibizumab. A band of reduced reflectivity below the RPE was identified in all three subjects that corresponded to areas of confirmed and suspected occult CNV on FA. After treatment, this band was reduced in volume in all patients. CONCLUSIONS High-speed 3-D OFDI at 1050 nm is a promising technology for imaging the retina and choroid in neovascular AMD. The developed system at 1050 nm provides good contrast for occult (type 1) CNV and may have advantages compared with time domain and current state of the art spectral domain OCT systems (SD-OCT) at 850 nm.

[1]  Rui Bernardes,et al.  Multimodal macula mapping: a new approach to study diseases of the macula. , 2002, Survey of ophthalmology.

[2]  Maciej Wojtkowski,et al.  High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. , 2006, Ophthalmology.

[3]  S. Yun,et al.  High-speed optical frequency-domain imaging. , 2003, Optics express.

[4]  S. Yun,et al.  In vivo high-resolution video-rate spectral-domain optical coherence tomography of the human retina and optic nerve. , 2004, Optics express.

[5]  J. Fujimoto,et al.  Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. , 2003, Archives of ophthalmology.

[6]  A. Fercher,et al.  Performance of fourier domain vs. time domain optical coherence tomography. , 2003, Optics express.

[7]  J. Fujimoto,et al.  In vivo retinal imaging by optical coherence tomography. , 1993, Optics letters.

[8]  M. V. D. van der Linden,et al.  Influence of cataract on optical coherence tomography image quality and retinal thickness , 2006, British Journal of Ophthalmology.

[9]  S. Yun,et al.  In vivo optical frequency domain imaging of human retina and choroid. , 2006, Optics express.

[10]  Wolfgang Drexler,et al.  Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology. , 2005, Ophthalmology.

[11]  I Hartl,et al.  Ultrahigh resolution real time OCT imaging using a compact femtosecond Nd:Glass laser and nonlinear fiber. , 2003, Optics express.

[12]  Teresa C. Chen,et al.  Ultrahigh-resolution high-speed retinal imaging using spectral-domain optical coherence tomography. , 2004, Optics express.

[13]  Teresa C. Chen,et al.  Retinal nerve fiber layer thickness map determined from optical coherence tomography images. , 2005, Optics express.

[14]  J. Duker,et al.  Ultrahigh-resolution, high-speed, Fourier domain optical coherence tomography and methods for dispersion compensation. , 2004, Optics express.

[15]  Teresa C. Chen,et al.  In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. , 2004, Optics letters.

[16]  Carmen A Puliafito,et al.  Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. , 2002, American journal of ophthalmology.

[17]  P.T.V.M. de Jong,et al.  Mechanisms of disease: Age-related macular degeneration , 2006 .

[18]  A. Fercher,et al.  In vivo human retinal imaging by Fourier domain optical coherence tomography. , 2002, Journal of biomedical optics.

[19]  A. Fercher,et al.  Measurement of intraocular distances by backscattering spectral interferometry , 1995 .

[20]  J. Fujimoto,et al.  High-speed optical coherence domain reflectometry. , 1992, Optics letters.

[21]  D. D. de Bruin,et al.  Spectrally balanced detection for optical frequency domain imaging. , 2007, Optics express.

[22]  Vincent Pierre-Kahn,et al.  [2/6--Age-related macular degeneration]. , 2009, Soins. Gerontologie.

[23]  Robert J Zawadzki,et al.  Clinical application of rapid serial fourier-domain optical coherence tomography for macular imaging. , 2006, Ophthalmology.

[24]  Changhuei Yang,et al.  Sensitivity advantage of swept source and Fourier domain optical coherence tomography. , 2003, Optics express.

[25]  J. Duker,et al.  Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. , 2005, Ophthalmology.

[26]  P. Lip,et al.  Age-related macular degeneration: an overview and update , 2006 .

[27]  W. Drexler,et al.  In vivo retinal optical coherence tomography at 1040 nm - enhanced penetration into the choroid. , 2005, Optics express.

[28]  J. Fujimoto,et al.  Optical coherence tomography: A new tool for glaucoma diagnosis , 1995, Current opinion in ophthalmology.

[29]  J. Fujimoto,et al.  In vivo endoscopic optical biopsy with optical coherence tomography. , 1997, Science.

[30]  B. Bouma,et al.  Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. , 2003, Optics letters.

[31]  Teresa C. Chen,et al.  High-speed imaging of human retina in vivo with swept-source optical coherence tomography. , 2006, Optics express.

[32]  T. Lai,et al.  Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study. , 2007, Ophthalmology.

[33]  A. Fercher,et al.  Full range complex spectral optical coherence tomography technique in eye imaging. , 2002, Optics letters.

[34]  Paul G. Updike,et al.  Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration. , 2008, Ophthalmology.

[35]  Eric A. Swanson,et al.  Quantitative Assessment of Macular Edema With Optical Coherence Tomography , 1995 .

[36]  Gabriel Coscas,et al.  Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. , 2007, American journal of ophthalmology.

[37]  J. Schuman,et al.  Optical coherence tomography. , 2000, Science.

[38]  J. Duker,et al.  Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. , 1996, Ophthalmology.

[39]  S. J. Talks,et al.  Correlation of optical coherence tomography, with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranes , 2005, British Journal of Ophthalmology.